Home JournalsJournal Details

ISSN: 2046-8954 eISSN: 2046-8962

Pharmaceutical Patent Analyst

Abbr. PHARM PAT ANAL

2.1

Latest IF

IF Trend

Recent Articles

Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment 2025-08-05

Bispecific anti-CD38/CD28 antibodies for treatment of multiple myeloma 2025-07-22

Patent highlights June — July 2024 2025-03-07

Trivalent bispecific anti-MSLN <sub>2</sub> /CD3 antibody for cancer treatment 2025-07-23

Emerging patents versus brain eating amoebae, <i>Naegleria fowleri</i> 2025-02-04

Development in medicinal chemistry <i>via</i> oxadiazole derivatives: patent spotlight 2020–2024 2025-05-07

From supplements to superbugs: how probiotic patent gaps drive antimicrobial resistance and the CRISPR-Cas solutions 2025-02-05

PLGA and cancer: a comprehensive patent-based review on the present state of art 2025-03-01

Patent highlights April–May 2024 2025-02-12

Patent spotlight on theranostics targeting fibroblast activation protein for personalized cancer care 2025-05-06

Developments in research and commercialization of PI3K and AKT targets: a patent-based landscape 2025-02-24

Contradicting rulings of the US patent office on double patenting jeopardize the generic and biosimilar drugs 2025-02-08

Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations 2025-05-15

Patent highlights February–March 2024 2024-10-23

Patent highlights December 2023–January 2024 2024-09-04

Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight 2024-06-20

Insights to the emerging potential of glucokinase activators as antidiabetic agent 2024-09-11

Catalyzing innovation in cancer drug discovery through artificial intelligence, machine learning and patency 2024-05-21

Patent highlights October–November 2023 2024-09-04

3D-printed immediate release solid dosage forms: a patent evaluation of US11622940B2 2024-09-04

Journal Info

ISSN

2046-8954

Abbr.

PHARM PAT ANAL

Analysis Services

Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.

Business Email

E-mail: product@genelibs.com